期刊
SCIENCE TRANSLATIONAL MEDICINE
卷 13, 期 579, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.abd1525
关键词
-
资金
- Human Vaccines Project
- NIAID
- Canadian Institutes for Health Research Rapid Response Grant for COVID-19
- Research Program on Emerging and Re-emerging Infectious Diseases from AMED [19fk0108113]
- NIAID [HHSN272201400008C, HHSN272201400006C, 75N93019C00052]
- Emory-UGA-CEIRS grant [HHSN272201400004C]
- ALSAC
- Wellcome Trust
- Bharat Biotech
The development and global deployment of COVID-19 vaccines are crucial in ending the pandemic, but challenges remain in elderly populations and low-resource settings, making distribution and vaccination efforts difficult.
Development of safe and effective COVID-19 vaccines is a global priority and the best hope for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been developed and shown to be efficacious and are already being deployed worldwide. Yet, many challenges remain. Immune senescence and comorbidities in aging populations and immune dysregulation in populations living in low-resource settings may impede vaccine effectiveness. Distribution of vaccines among these populations where vaccine access is historically low remains challenging. In this Review, we address these challenges and provide strategies for ensuring that vaccines are developed and deployed for those most vulnerable.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据